Post-Transplantation Lymphoproliferative Disorders Solid-organ and hematopoietic stem-
cell transplants are widely used for various life-threatening medical disorders. Prophylaxis …

Epstein-Barr virus-related post-transplant lymphoproliferative disorders are recognized as a
significant cause of morbidity and mortality in patients undergoing hematopoietic stem cell …

These updated guidelines from the American Society of Transplantation Infectious Diseases
Community of Practice review the diagnosis, management, and prevention of post …

Objectives: We undertook a systematic review of 404 published cases of Castleman's
disease to identify the role of the surgeon beyond assistance in tissue-based diagnosis …

Background Post-transplantation lymphoproliferative disorder (PTLD) develops in 1–10% of
transplant recipients and can be Epstein–Barr virus (EBV) associated. To improve long-term …

Post-transplant lymphoproliferative diseases (PTLD) associated with Epstein-Barr virus
(EBV) infection often develop after organ and haematopoietic stem-cell transplantation …

We examined the associations of Epstein–Barr virus (EBV) status with characteristics and
outcomes of posttransplantation lymphoproliferative disorder (PTLD) by studying 176 adult …

Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal disorder arising after
solid organ transplant (SOT) or hematopoietic stem cell transplant (HSCT). Iatrogenically …

Posttransplant lymphoproliferative disorder (PTLD) is recognized as potentially one of the
most devastating complications of organ transplantation. The Epstein–Barr virus (EBV) …

Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, affecting up to 90% of the population.
EBV was first identified as an oncogenic virus in a Burkitt lymphoma cell line, though …